NASDAQ:AXON - Axon Enterprise Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $183.50
  • Forecasted Upside: 18.20 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$155.25
▲ +2.7 (1.77%)
1 month | 3 months | 12 months
Get New Axon Enterprise Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AXON and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AXON

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$183.50
▲ +18.20% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Axon Enterprise in the last 3 months. The average price target is $183.50, with a high forecast of $200.00 and a low forecast of $170.00. The average price target represents a 18.20% upside from the last price of $155.25.
Buy
The current consensus among 5 investment analysts is to buy stock in Axon Enterprise.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/22/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/18/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/14/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/15/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/26/2021Northland SecuritiesInitiated CoverageBuy$170.00Medium
i
Rating by Michael Latimore at Northland Securities
2/26/2021Needham & Company LLCReiterated RatingBuyHigh
i
2/26/2021Robert W. BairdBoost Price TargetOutperform$135.00 ➝ $200.00High
i
2/12/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$129.00 ➝ $179.00Low
i
2/1/2021Morgan StanleyInitiated CoverageOverweight$185.00Low
i
10/23/2019JMP SecuritiesReiterated RatingOutperform$28.00 ➝ $32.00Low
i
2/11/2019JMP SecuritiesReiterated RatingBuy$6.00Medium
i
12/17/2018Jefferies Financial GroupUpgradeHold ➝ Buy$3.00High
i
11/11/2018OppenheimerReiterated RatingHoldHigh
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
9/20/2018CowenReiterated RatingHoldLow
i
8/13/2018HC WainwrightReiterated RatingBuy$7.00Medium
i
7/9/2018OppenheimerReiterated RatingHoldLow
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
6/12/2018OppenheimerReiterated RatingHoldLow
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
6/11/2018Jefferies Financial GroupBoost Price TargetHold$3.00 ➝ $5.00High
i
6/7/2018HC WainwrightReiterated RatingBuyHigh
i
6/6/2018OppenheimerReiterated RatingHoldHigh
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
6/6/2018Chardan CapitalReiterated RatingHold$4.00High
i
Rating by G. Amusa at Chardan Capital
2/13/2018CowenReiterated RatingHoldHigh
i
2/13/2018OppenheimerReiterated RatingHoldHigh
i
Rating by Jay Olson at Oppenheimer Holdings Inc.
1/12/2018CowenDowngradeOutperform ➝ Market PerformHigh
i
1/10/2018Chardan CapitalUpgradeSell ➝ Neutral$2.50 ➝ $2.50Low
i
Rating by G. Amusa at Chardan Capital
12/21/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$6.00High
i
Rating by Eun Yang at Jefferies Financial Group Inc.
12/1/2017HC WainwrightReiterated RatingBuy$11.00Medium
i
11/12/2017OppenheimerReiterated RatingHoldN/A
i
11/10/2017Piper Jaffray CompaniesReiterated RatingHoldN/A
i
11/3/2017Chardan CapitalReiterated RatingSell$3.00N/A
i
11/1/2017Robert W. BairdReiterated RatingHold$6.00N/A
i
10/19/2017HC WainwrightReiterated RatingBuyN/A
i
10/6/2017Chardan CapitalReiterated RatingSell$3.00N/A
i
9/27/2017HC WainwrightReiterated RatingBuy$11.00Low
i
9/27/2017Jefferies Financial GroupReiterated RatingBuy$12.00High
i
9/26/2017Evercore ISIReiterated RatingOutperform$30.00 ➝ $9.00High
i
9/26/2017CowenReiterated RatingOutperform$30.00 ➝ $25.00High
i
9/26/2017OppenheimerDowngradeOutperform ➝ Market PerformHigh
i
9/26/2017JMP SecuritiesReiterated RatingOutperform$36.00 ➝ $19.00N/A
i
9/26/2017Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$32.00 ➝ $9.00N/A
i
9/26/2017UBS GroupDowngradeOutperform ➝ Market PerformN/A
i
9/26/2017Robert W. BairdDowngradeOutperform ➝ Neutral$29.00 ➝ $6.00N/A
i
9/25/2017OppenheimerReiterated RatingOutperform ➝ Buy$30.00High
i
9/23/2017Chardan CapitalReiterated RatingSell ➝ Sell$3.00High
i
9/14/2017Chardan CapitalReiterated RatingSell$8.00Medium
i
9/8/2017Evercore ISIInitiated CoverageOutperform ➝ Outperform$30.00High
i
8/25/2017Jefferies Financial GroupSet Price TargetBuy$40.00High
i
7/10/2017Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$40.00Low
i
6/21/2017CowenReiterated RatingOutperform$30.00Medium
i
6/14/2017CIBCBoost Price TargetOutperform ➝ Outperform$26.00 ➝ $30.00High
i
6/14/2017OppenheimerBoost Price TargetOutperform$26.00 ➝ $30.00Medium
i
6/13/2017CowenReiterated RatingOutperform$22.00 ➝ $30.00High
i
6/9/2017Jefferies Financial GroupReiterated RatingBuy$31.00Low
i
4/18/2017CIBCBoost Price TargetNeutral$30.00 ➝ $33.00Low
i
4/18/2017Jefferies Financial GroupReiterated RatingBuy$31.00Low
i
4/17/2017OppenheimerBoost Price TargetNeutral$30.00 ➝ $33.00Low
i
4/14/2017OppenheimerReiterated RatingOutperform$20.00 ➝ $26.00Low
i
4/12/2017Piper Jaffray CompaniesReiterated RatingOverweight$32.00Low
i
3/22/2017OppenheimerReiterated RatingBuyMedium
i
2/14/2017HC WainwrightSet Price TargetBuy$35.00N/A
i
2/14/2017CowenInitiated CoverageOutperformN/A
i
2/13/2017Piper Jaffray CompaniesReiterated RatingPositive$32.00N/A
i
2/9/2017OppenheimerSet Price TargetBuy$20.00N/A
i
2/3/2017CowenInitiated CoverageOutperform$22.00N/A
i
1/15/2017OppenheimerReiterated RatingOutperform$20.00N/A
i
12/25/2016OppenheimerSet Price TargetBuy$20.00N/A
i
12/20/2016Robert W. BairdReiterated RatingPositive$29.00N/A
i
12/20/2016LaidlawInitiated CoverageSell$7.50N/A
i
12/18/2016Piper Jaffray CompaniesSet Price TargetBuy$32.00N/A
i
12/15/2016OppenheimerReiterated RatingBuy$20.00N/A
i
12/6/2016OppenheimerInitiated CoverageOutperform$20.00N/A
i
11/25/2016Robert W. BairdReiterated RatingOutperform$29.00N/A
i
11/17/2016Jefferies Financial GroupReiterated RatingBuy$31.00N/A
i
11/8/2016HC WainwrightReiterated RatingBuyN/A
i
11/8/2016JMP SecuritiesReiterated RatingBuyN/A
i
10/24/2016Robert W. BairdReiterated RatingOutperform$29.00N/A
i
9/26/2016Jefferies Financial GroupReiterated RatingBuy$31.00N/A
i
9/23/2016Robert W. BairdReiterated RatingOutperform$29.00N/A
i
9/23/2016Evercore ISIReiterated RatingBuy$29.00N/A
i
9/23/2016Piper Jaffray CompaniesSet Price TargetBuy$32.00N/A
i
8/17/2016HC WainwrightReiterated RatingBuyN/A
i
8/16/2016JMP SecuritiesReiterated RatingOutperform$36.00N/A
i
6/30/2016SVB LeerinkReiterated RatingBuyN/A
i
6/7/2016HC WainwrightReiterated RatingBuyN/A
i
6/7/2016SVB LeerinkInitiated CoverageOutperform$22.00N/A
i
Rating by P. Matteis at SVB Leerink LLC
(Data available from 4/14/2016 forward)
Axon Enterprise logo
Axon Enterprise, Inc. engages in the development, manufacturing, and sale of conducted electrical weapons for personal defense. It operates through the TASER Weapons and Software and Sensors segments. The TASER Weapons segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
Read More

Today's Range

Now: $155.25
$155.06
$155.56

50 Day Range

MA: $148.45
$133.45
$170.00

52 Week Range

Now: $155.25
$65.50
$212.37

Volume

408 shs

Average Volume

646,772 shs

Market Capitalization

$10.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Frequently Asked Questions

What sell-side analysts currently cover shares of Axon Enterprise?

The following equities research analysts have issued reports on Axon Enterprise in the last twelve months: JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Securities, Robert W. Baird, and Zacks Investment Research.
View the latest analyst ratings for AXON.

What is the current price target for Axon Enterprise?

4 Wall Street analysts have set twelve-month price targets for Axon Enterprise in the last year. Their average twelve-month price target is $183.50, suggesting a possible upside of 18.2%. Robert W. Baird has the highest price target set, predicting AXON will reach $200.00 in the next twelve months. Northland Securities has the lowest price target set, forecasting a price of $170.00 for Axon Enterprise in the next year.
View the latest price targets for AXON.

What is the current consensus analyst rating for Axon Enterprise?

Axon Enterprise currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AXON will outperform the market and that investors should add to their positions of Axon Enterprise.
View the latest ratings for AXON.

What other companies compete with Axon Enterprise?

Other companies that are similar to Axon Enterprise include Microsoft, Oracle, ServiceNow, VMware, Fortinet, Proofpoint, C3.ai, Qualys, Commvault Systems, Progress Software and FalconStor Software.

How do I contact Axon Enterprise's investor relations team?

Axon Enterprise's physical mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company's listed phone number is (480) 991-0797. The official website for Axon Enterprise is www.axovant.com.